Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1995 3
1996 3
1997 9
1998 4
1999 6
2000 8
2001 1
2002 6
2003 6
2004 7
2005 7
2006 10
2007 15
2008 13
2009 8
2010 10
2011 19
2012 19
2013 20
2014 21
2015 24
2016 22
2017 22
2018 23
2019 33
2020 40
2021 49
2022 27
2023 33
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Results by year

Filters applied: . Clear all
Page 1
Spatial multimodal analysis of transcriptomes and metabolomes in tissues.
Vicari M, Mirzazadeh R, Nilsson A, Shariatgorji R, Bjärterot P, Larsson L, Lee H, Nilsson M, Foyer J, Ekvall M, Czarnewski P, Zhang X, Svenningsson P, Käll L, Andrén PE, Lundeberg J. Vicari M, et al. Among authors: svenningsson p. Nat Biotechnol. 2023 Sep 4. doi: 10.1038/s41587-023-01937-y. Online ahead of print. Nat Biotechnol. 2023. PMID: 37667091
Editorial: Update on movement disorders.
Svenningsson P, Frucht SJ. Svenningsson P, et al. Curr Opin Neurol. 2019 Aug;32(4):564-565. doi: 10.1097/WCO.0000000000000709. Curr Opin Neurol. 2019. PMID: 31246704 No abstract available.
Editorial: Update on movement disorders.
Svenningsson P. Svenningsson P. Curr Opin Neurol. 2021 Aug 1;34(4):539-540. doi: 10.1097/WCO.0000000000000949. Curr Opin Neurol. 2021. PMID: 33967200 No abstract available.
Repurposing GLP1 agonists for neurodegenerative diseases.
Markaki I, Winther K, Catrina SB, Svenningsson P. Markaki I, et al. Among authors: svenningsson p. Int Rev Neurobiol. 2020;155:91-112. doi: 10.1016/bs.irn.2020.02.007. Epub 2020 Aug 11. Int Rev Neurobiol. 2020. PMID: 32854860 Review.
Paroxysmal Kinesigenic Dyskinesia.
Paucar M, Malmgren H, Svenningsson P. Paucar M, et al. Among authors: svenningsson p. Tremor Other Hyperkinet Mov (N Y). 2017 Dec 12;7:529. doi: 10.7916/D8R79N2F. eCollection 2017. Tremor Other Hyperkinet Mov (N Y). 2017. PMID: 29276650 Free PMC article.
Expanding the GPCR-RAMP interactome.
Kotliar IB, Bendes A, Dahl L, Chen Y, Saarinen M, Ceraudo E, Dodig-Crnković T, Uhle'n M, Svenningsson P, Schwenk JM, Sakmar TP. Kotliar IB, et al. Among authors: svenningsson p. bioRxiv [Preprint]. 2023 Nov 23:2023.11.22.568247. doi: 10.1101/2023.11.22.568247. bioRxiv. 2023. PMID: 38045268 Free PMC article. Preprint.
β2-Adrenoreceptor Agonists, Montelukast, and Parkinson Disease Risk.
Liu B, Svenningsson P, Ludvigsson JF, Lundholm C, Wallin J, Larsson H, Sjölander A, Williams DM, Pedersen NL, Wirdefeldt K. Liu B, et al. Among authors: svenningsson p. Ann Neurol. 2023 May;93(5):1023-1028. doi: 10.1002/ana.26638. Epub 2023 Mar 23. Ann Neurol. 2023. PMID: 36897287
429 results